Pentagestrone: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 62: | Line 62: | ||
{{Progesterone receptor modulators}} |
{{Progesterone receptor modulators}} |
||
[[Category:Abandoned drugs]] |
|||
[[Category:Ethers]] |
[[Category:Ethers]] |
||
[[Category:Pregnanes]] |
[[Category:Pregnanes]] |
||
Revision as of 20:41, 29 October 2017
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H38O3 |
| Molar mass | 398.57812 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Pentagestrone (INN), also known as 17α-hydroxyprogesterone 3-cyclopentyl enol ether, is a steroidal progestin of the 17α-hydroxyprogesterone group that was never marketed.[1][2] An acetate ester, pentagestrone acetate (Gestovis, Gestovister), has been marketed for clinical use.[1] Pentagestrone was described in the literature in 1960.[1]
See also
References
- ^ a b c J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 943–. ISBN 978-1-4757-2085-3.
- ^ Camille Georges Wermuth (2 May 2011). The Practice of Medicinal Chemistry. Academic Press. pp. 731–. ISBN 978-0-08-056877-5.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |